The Glasgow Biomarker Research Unit (formerly the Metabolic Medicine Lab) is based in the British Heart Foundation Glasgow Cardiovascular Research Centre at the University of Glasgow, and at the Queen Elizabeth University Hospital.
Our mission is to offer a competitive one-stop shop that advises and supports the clinical community through sample storage and analysis.
We facilitate clinical research for local, national, and international studies, by way of receipt, processing, archiving, shipment, and analysis of blood, urine, saliva, and other biological material.
Our primary focus is on research-orientated batch analysis of frozen clinical samples for core clinical blood tests, as well as selected specialist tests. By offering a research-orientated service, our costs are kept lower than comparable fully accredited laboratories that inform clinical care. Our laboratory is GCP and GCLP compliant, and our Quality Control processes ensure our focus on quality is never compromised. 
We have established links with many suppliers and have worked with a range of industrial partners including AstraZeneca and Roche Diagnostics, and we are active partners in the Roche-Glasgow CoCE-HF collaboration.
GlasBRU is open to academic and commercial collaboration with a wide range of biomarker assays.
In addition, we participate in UKNEQAS External Quality Assessment for Cardiac Biomarkers scheme for selected biomarkers.
An internationally recognised multi-field leading sample analysis service.
Internal collaborations:
- Heart Failure
- Cardiac
- Metabolic/Diabetes
- Obesity